Summit Therapeutics (SMMT) Earnings
|
Expand Research on SMMT
| Next EPS Date | 8/6/26 *Est. | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -62.5% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -3.2% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/7/26 |
Q126 | N/A | -GBP0.17 | N/A | N/A | GBP1.6M | N/A | N/A | N/A | ||
| 2/23/26 | Q425 | -GBP0.29 | -GBP0.08 | -GBP0.21 | N/A | N/A | N/A | ![]() | ![]() | Details | |
| 10/20/25 | Q325 | -GBP0.13 | -GBP0.17 | +GBP0.04 | N/A | N/A | N/A | ![]() | ![]() | Details | |
| 8/11/25 | Q225 | -GBP0.12 | -GBP0.09 | -GBP0.03 | N/A | N/A | N/A | ![]() | ![]() | Details | |
| 8/6/25 |
Q225 | N/A | -GBP0.09 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/1/25 | Q125 | -GBP0.07 | -GBP0.09 | +GBP0.02 | N/A | N/A | N/A | ![]() | ![]() | Details | |
| 2/24/25 | Q424 | -GBP0.07 | -GBP0.08 | +GBP0.01 | N/A | N/A | N/A | ![]() | ![]() | Details | |
| 10/30/24 | Q324 | -GBP0.05 | -GBP0.07 | +GBP0.02 | N/A | N/A | N/A | ![]() | ![]() | Details |


